Clinical Trial: Study of Effect of Azeliragon in Patients Refractory to First-Line Metastatic Pancreatic Cancer
Study Status: Completed
Recruit Status: RECRUITING
Condition: Metastatic Pancreatic Cancer
Study Type: INTERVENTIONAL
Official Title: A Phase I/II Open Label Study to Assess Safety and Preliminary Evidence of a Therapeutic Effect of Azeliragon in Patients Refractory to First-Line Treatment of Metastatic Pancreatic Cancer
Brief Summary:
This is an open label study to determine the safety and preliminary evidence of a therapeutic effect of azeliragon in patients refractory to first-line or second-line treatment of metastatic pancreatic cancer.
Read more